Request Call Back

Contact Us

Deep Vein Thrombosis (DVT)
*    Denotes required field.

   * First Name 

   * Last Name 

   * Email 

Phone 

Cell Phone 

Street Address 

Zip Code 

City 

State 

Please describe blood clots:

If you believe the blood clots developed as the result of a drug, please list drug:

   * Please describe your case:

For verification purposes, please answer the below question:
+
=

No Yes, I agree to the Parker Waichman LLP disclaimers. Click here to review.

Yes, I would like to receive the Parker Waichman LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Deep Vein Thrombosis

Deep Vein Thrombosis Disease Injury Lawsuits

Deep Vein Thrombosis (DVT) | Lawsuits, Lawyers | Disease: Injury, Infection | Side Effects, Prescription Drugs, Medications, HRT drugs, COX-II Inhibitors, Ortho Evra Patch

In recent months, the birth control patch Ortho-Evra has been linked to blood clots and deep vein thrombosis (DVT). In July 2005, a major news source published their own findings indicating Ortho Evra patch use can triple a patient’s risk of encountering deep vein thrombosis  (DVT) symptoms or other serious side effects.

The women using the birth control patch who developed deep vein thrombosis (DVT) symptoms, some have died as a result of life threatening complications. Other studies have illustrated that using the Ortho Evra birth control patch may cause a woman to develop deep vein thrombosis (DVT) symptoms independent of other blood clot risk factors. Deep vein thrombosis (DVT)can lead to a very serious and life threatening condition called pulmonary embolism, when the blood clot breaks away and travels to the lungs.

Prior to approval, the FDA medical review expressed concerns about Ortho Evra causing venous thromboembolisms, stating: “Post-marketing surveillance for DVT (Deep Vein Thrombosis) and PE (Pulmonary Embolism) events will be important, as there are potential serious adverse risks (with two cases of pulmonary emboli in the clinical trials) with this new delivery system for contraception.”

Pateints who take or have taken Vioxx are at an increased risk of developing pulmonary embolism (PE) and deep vein thrombosis (DVT). Vioxx promotes the formation of blood clots, which can then cause pulmonary embolism (PE) and can then result in deep vein thrombosis (DVT) symptoms.

Deep vein thrombosis (DVT) is the progression of a blood clot (thrombus) in the deep veins of the legs, arms, or pelvis. Clots can develop in superficial veins (called superficial thrombophlebitis) and in deep veins. Blood clots in superficial veins rarely cause serious problems, and clots in deep veins require immediate medical evaluation

Deep vein blood clots can grow in size, break loose, and then travel through the bloodstream to the lungs, resulting in life-threatening pulmonary embolism. Deep vein thrombosis may also cause other long-term complications. In approximately 25% of cases, deep vein thrombosis damages the affected vein and leads to long-lasting postthrombotic syndrome. This condition causes pain, swelling, discoloration, and leg sores.

Blood clots can form in veins when you are inactive: for instance, if you are paralyzed, bedridden, or even during a long flight or car trip. Surgery or an injury can damage your blood vessels and cause a clot to form. Deep vein thrombosis can also be caused by cancer or an inherited tendency to clot more quickly.

Prior to approval, the FDA medical review expressed concerns about Ortho Evra causing venous thromboembolisms, stating: “Post-marketing surveillance for DVT (Deep Vein Thrombosis) and PE (Pulmonary Embolism) events will be important, as there are potential serious adverse risks (with two cases of pulmonary emboli in the clinical trials) with this new delivery system for contraception.”

Symptoms of deep vein thrombosis include generalized swelling of the affected leg. When measured, the affected leg may be larger than the other leg. Also, your affected leg may feel warm and be redder than the other leg. You may have pain or tenderness in the calf or thigh when it is touched or squeezed or with movement or standing. Calf or thigh pain may become constant and increase with squeezing or movement.

If a deep vein thrombus is small, it may not cause symptoms. In some cases, pulmonary embolism is the first sign that you have deep vein thrombosis.

Legal Help For Victims Affected By Deep Vein Thrombosis

If you or a loved one has been diagnosed with Deep vein thrombosis as a result of taking HRT drugs, COX-II Inhibitors or the Ortho Evra Patch, please fill out the form at the right for a free case evaluation by a qualified defective drug attorney or call us at 1-800-YOURLAWYER (1-800-968-7529).



 

Deep Vein ThrombosisRSS Feed

Study Finds Ways To Improve Detection Of Blood Clots In The Lung

Jun 1, 2006 | www.medicalnewstoday.com
A new study of a commonly used imaging test of the chest to detect potentially deadly blood clots in the lung shows that extending the scan to the legs "where the clots typically originate" or adding a standard clinical assessment significantly improves physicians' abilities to accurately diagnose pulmonary embolism. A sudden and potentially deadly blockage in a lung artery, pulmonary embolism affects an estimated 600,000 Americans each year, making it the fourth most commonly occurring...

Parker & Waichman, LLP Files Suit Against Ortho-McNeil Pharmaceutical, Inc. on Behalf of 33-Year-Old Woman Diagnosed with Bilateral Pulmonary Embolism and Deep Venous Thrombosis After Using Ortho Evra Birth Control Patch for Two Months - JNJ

May 19, 2006 | PrimeZone
Parker & Waichman, LLP (www.yourlawyer.com) announced that it has filed suit against Ortho-McNeil Pharmaceutical, Inc., a division of Johnson and Johnson Inc. (NYSE:JNJ), on behalf of a 33-year-old woman and her husband. The woman suffered a bilateral pulmonary embolism and deep venous thrombosis (DVT) after using Ortho Evra for two months. The suit was filed in the United States District Court for the District of New Jersey in Newark, New Jersey. For more information on Ortho Evra and this...

Study Suggests Additional Risk Factors besides Inactivity May Trigger Deadly Blood Clots on Long Flights

Mar 12, 2006 | Newsinferno News Staff
For several years, “economy class syndrome” has been a term used to describe life-threatening blood clots associated with restrictive seating, inactivity during long flights, and frequent flying. A recent study published in Lancet suggests that additional conditions present during air travel may add to the risk of developing deep vein thrombosis (DVT). When 71 volunteers were tested, it was found that certain chemicals associated with clotting were higher during an eight-hour...

New air travel clot risk theory

Mar 10, 2006 | BBC News
Sitting still for long periods cannot alone explain why air passengers are at higher risk of potentially deadly blood clots, research suggests. The risk of developing deep vein thrombosis is thought to be raised by air travel - particularly long flights. But a Lancet study by Dutch researchers found chemicals indicating clotting in 71 volunteers were higher during eight hours on a flight than in the cinema. It suggests low air pressure and oxygen levels on a flight may play a role. Deep...

More Deep Vein Thrombosis News

Parker Waichman Accolades And Reviews Best Lawyers Find Us On Avvo